Aspivix

Aspivix is a medical device company in womens health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, CarevixTM, is the worlds first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. CarevixTM is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. CarevixTM study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the...

Medical device,woman's care,gynaecology,woman's health,medtech,start-up,innovation,iud,hysteroscopy,cervical biopsy,reproductive health,femtech,obgyn,midwife,pain reduction,ivf,fertility treatment,and women's health

Aspivix operates in the Medical equipment manufacturing industry.

Aspivix's revenue is 1m - 10m

Aspivix has 11 - 50 employees.